Enzymedica Inc. launches new product for healthy weight management

January 7, 2012 — Florida based enzyme manufacturer Enzymedica Inc. has launched Slender GR. Slender GR includes a proprietary enzyme blend called Glucoreductase, along with lipase, superoxide dismutase (SOD) and rice bran, to support healthy weight loss and convert wholesome foods into usable energy.*

Slender GR and the enzyme blend Glucoreductase are featured in Eat for Life-The Ultimate Weight-Loss Breakthrough. (2011, Better Health Publications, author Harvey Diamond, the New York Times best selling co-author of Fit for Life.)**

“The obstacles to maintaining a strict regimen associated with the typical weight-loss program are many,” explains Dr. Steven Lamm, a practicing internist and faculty member at New York University School of Medicine.** “Slender GR was developed as part of a healthy yet forgiving eating lifestyle. The triple action formula provides unique metabolic and digestive support for a whole food, but perhaps less-than-perfect, diet.”*

The synergy of the ingredients in Slender GR optimizes sugar and fat metabolism, encourages a lower glycemic index, and promotes healthy detoxification.*

Glucoreductase blend:

• Converts carbohydrates to soluble fiber, reducing absorbable sugars*
• Encourages a lower glycemic index*
• Supports balanced blood sugar levels already within a normal range*

Lipase Thera-blend:

• Increases fat metabolism*
• Superoxide Dismutase (SOD)
• Reduces oxidative stress*
• Promotes healthy detoxification*

Rice bran:

• Promotes healthy elimination & facilitates toxin removal*
• Fiber supports satiety*
• Synergistic effect with Glucoreductase

“I recommend taking one capsule at the beginning of each meal,” says Lamm. “Two capsules may be taken with larger meals, or meals containing starch such as pasta, bread or similar. One to two capsules may also be taken with a high calorie food or beverage.”

Source: Enzymedica, www.enzymedica.com

** Harvey Diamond and Steven Lamm are compensated advisors to Enzymedica Inc.

i   Blum, James. (2011). Evaluation of a novel supplement to reduce blood glucose through the use of a modified oral glucose tolerance test. Am J Transl Res., 3(2), 219-25.

ii Vincent, HK. (2006). Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. International Journal of Obesity, 30, 400-18.

iii Shih, Ling-Ying. (2006). Leptin, Superoxide Dismutase, and weight loss: initial leptin predicts weight loss. Obesity, 14(12), 2184-92.

iv Weickert, M. (2006). Cereal fiber improves whole body insulin sensitivity in overweight and obese women. Diabetes Care, 29, 775-80.